S7High mortality from invasive pneumococcal pneumonia in the era of vaccine preventable diseaseIntroduction and Objectives Bacteraemia secondary to pneumococcal pneumonia is the most common presentation of invasive pneumococcal disease (IPD) and is associated with high mortality rates.1 We conducted this ...
This work was approved by the UK NHS Research Ethics Committee (NHS REC Number 10/WNo03/40) and was listed on the NIHR Clinical Research Network portfolio. All subjects provided informed consent and, in accordance with the UK mental capacity act, a consultee provided assent on behalf of thos...
The Great Britain Department of Health confirmed last week that a pounds 6.80 IOS payment had been agreed for the first phase of the campaign, which has been limited to the over-80s in England this year due to a shortage of vaccine. 年份: 2003 ...
from 35 studies reported from 16 countries in Western Europe which found that serotype 14 was the most common in a patient population aged <18 years, ranging from 19% to 47%.23 This strain is included in Prevnar, a heptavalent pneumococcal conjugate vaccine (PCV7) approved by the FDA in ...
Vaccine protection against Staphylococcus aureus pneumonia. The Journal of experimental medicine 205, 287–294 (2008). 20. Walker, B. & Bayley, H. Key residues for membrane binding, oligomerization, and pore forming activity of staphylococcal alpha- hemolysin identified by cysteine scanning mutagenesis...